ReShape Lifesciences Inc. announced the signing of a preferred partner agreement with Hive Medical (Hive). Hive's software suite leverages AI, machine-learning, SMS, and patient self-service technology to increase patient volume.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.173 USD | +3.16% | +0.71% | -31.72% |
12/04 | North American Morning Briefing : Big Banks Kick -2- | DJ |
01/04 | Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.72% | 3.93M | |
+11.29% | 221B | |
+8.75% | 186B | |
+14.39% | 137B | |
+27.37% | 109B | |
-0.04% | 63.09B | |
+14.28% | 52.68B | |
+4.86% | 50.86B | |
+7.62% | 42.53B | |
+7.22% | 37.76B |
- Stock Market
- Equities
- RSLS Stock
- News ReShape Lifesciences Inc.
- Reshape Lifesciences Inc. Signs Preferred Partner Agreement with Hive Medical for Lead Optimization Software